Jazz Pharmaceuticals Enters Material Definitive Agreement
Ticker: JAZZ · Form: 8-K · Filed: Apr 8, 2025 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, 8-k
TL;DR
Jazz Pharma signed a big deal, 8-K filed.
AI Summary
On April 7, 2025, Jazz Pharmaceuticals plc entered into a material definitive agreement. The company, incorporated in Ireland with its principal executive offices in Dublin, filed an 8-K report detailing this agreement. This filing also includes financial statements and exhibits related to the event.
Why It Matters
This filing indicates a significant new contract or deal for Jazz Pharmaceuticals, which could impact its future financial performance and strategic direction.
Risk Assessment
Risk Level: medium — Entering into material definitive agreements can carry inherent risks related to the terms, counterparty, and execution of the agreement.
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Registrant
- April 7, 2025 (date) — Date of earliest event reported
- Ireland (location) — Jurisdiction of Incorporation
- Dublin (location) — Principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Jazz Pharmaceuticals?
The 8-K filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the summary information.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 7, 2025.
Where are Jazz Pharmaceuticals' principal executive offices located?
Jazz Pharmaceuticals' principal executive offices are located at Fifth Floor, Waterloo Exchange, Waterloo Road, Dublin 4, Ireland.
What is the SEC Act under which this 8-K report is filed?
This 8-K report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the SIC code for Jazz Pharmaceuticals?
The Standard Industrial Classification (SIC) code for Jazz Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding Jazz Pharmaceuticals plc (JAZZ).